↓ Cooling
Business
fiercepharma.com
Coverage by fiercepharma.com as tracked by Newsylist.
5trends covered
0broke first
5articles tracked
◼ Archived
Business
🔮 holds ✗
The Surprising Reason This Biotech Plummeted 69%
EyePoint Pharmaceuticals shares cratered following a late-stage trial setback for its flagship eye disease drug.
◼ Archived
Business
🔮 fades ✓
Eli Lilly takes aim at illicit market for its experimental weight-loss drug
Eli Lilly sues six firms to shut down a black‑market trade in its experimental obesity drug retatrutide.
◼ Archived
Business
🔮 fades ✓
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
◼ Archived
Business
🔮 holds ✗
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
9 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.